Swedish Orphan Biovitrum AB (publ) banner

Swedish Orphan Biovitrum AB (publ)
STO:SOBI

Watchlist Manager
Swedish Orphan Biovitrum AB (publ) Logo
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Watchlist
Price: 427.8 SEK -1.52% Market Closed
Market Cap: kr152.3B

Wall St Price Targets

SOBI Price Forecast
Based on 16 analysts

+23% Upside
from kr427.8 today

Swedish Orphan Biovitrum AB (publ) (SOBI)’s 12-month stock price forecast through October 2027 has a consensus target of kr525.3, implying 23% upside. The forecast is based on price targets from 16 Wall Street analysts.

SOBI Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for SOBI yet.

Swedish Orphan Biovitrum AB (publ) Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SOBI's stock price target?
Price Target
525.3 SEK

According to Wall Street analysts, the average 1-year price target for SOBI is 525.3 SEK with a low forecast of 353.5 SEK and a high forecast of 619.5 SEK.

What is the Revenue forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 8 years is 9%.

What is the Gross Profit forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 8 years is 9%.

What is the Operating Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%

The compound annual growth rate for Operating Income over the next 8 years is 9%.

What is the Pre-Tax Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
603%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 603%.

What is the Net Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
43%

The compound annual growth rate for Net Income over the next 8 years is 43%.

Back to Top